Open access
Sep 2026
An acid-responsive nanoagonist delivering chemotherapy-derived tumor antigens to assist cancer immunotherapy
Immunotherapy is being actively explored for malignant tumors through various approaches, with recent success exemplified by immune checkpoint inhibitors (ICIs), which function by restoring T-cell activity to eliminate tumor cells. Some chemotherapeutic drugs synergistically improve the therapeutic effect of ICIs...
Xing-Yu Zhou, Bo Chen, Ke-Cheng Wu et al.
· Journal of Nanobiotechnology · 0 citations